Clinical homogeneity and genetic heterogeneity in Weill–Marchesani syndrome

Abstract

Weill-Marchesani syndrome (WMS) is a rare condition characterized by short stature, brachydactyly, joint stiffness, and characteristic eye abnormalities including microspherophakia, ectopia of lens, severe myopia, and glaucoma. Both autosomal recessive (AR) and autosomal dominant (AD) modes of inheritance have been described for WMS. A locus for AR WMS has recently been mapped to chromosome 19p13.3-p13.2 while mutation within the fibrillin-1 gene (15q21.1) was found in one AD WMS family. In order to answer the question of whether or not genetic heterogeneity could be related to a clinical heterogeneity, we reviewed 128 WMS patients from the literature (including 57 AR, 50 AD, and 21 sporadic cases), with a particular attention to clinical features. Statistical analyses using Fischer exact test were used to compare the proportions of 12 clinical parameters between AR and AD patients. There was no significant difference between both groups for myopia, glaucoma, cataract, short stature, brachydactyly, thick skin, muscular build, and mental retardation. Significant results were found for microspherophakia (94% in AR, 74% in AD, Fischer 0.007), ectopia lentis (64% in AR, 84% in AD, Fischer 0.016), joint limitations (49% in AR, 77% in AD, Fischer 0.010), and cardiac anomalies (39% in AR, 13% in AD, Fischer 0.004). Nevertheless, we failed to distinguish AR from AD inheritance in individual cases. These results support the clinical homogeneity but the genetic heterogeneity of WMS.

Molecular pathogenesis and management strategies of ectopia lentis

“…45 The characteristic ocular features include myopia and EL (commonly manifesting as microspherophakia). Although causative heterozygous mutations in FBN1 has been described, 46 it is more commonly inherited in an autosomal recessive manner, caused by mutations in ADAMTS10 47,48 on 19p13.2.…”

The new Ghent criteria for Marfan syndrome: what do they change?

“…However, it raises some comments: (i) When a patient is diagnosed with another condition in the absence of aortic dilatation (ELS, MASS, MVPS), physicians need to be aware that regular follow-up including annual cardiovascular imaging is advised to monitor aortic size over time, because it has been shown that aortic dilatation can appear at all ages (23)(24)(25)(26)(27)(28)(29). Reclassification to MFS may occur if aortic dilatation appears during follow-up, as shown in the past (30,31).…”

“…Four patients with autosomal dominant Weill-Marchesani syndrome were not assessed because they represented another well-defined type I fibrillinopathy (24)(25)(26). A cohort of 1009 patients was thus constituted.…”

Employing molecular genetics of chondrodysplasias to inform the study of osteoarthritis

“…#608328) results from fibrillin 1 mutations. A review of 128 cases of Weill-Marchesani syndrome showed that joint limitations were more common in the dominant form of the disease (33). The recessive and dominant forms of Weill-Marchesani syndrome are phenocopies, implicating ADAMTS-10 and fibrillin 1 as components of a common molecular pathway (33).…”